Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Larotaxel vs 5-FU/Capecitabine in Advanced Pancreatic Cancer
NCT00417209Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of larotaxel in pancreatic cancer (PC), sponsored by Sanofi. Started Dec 2006; status: completed.
02
Drugs
larotaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00417209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417209.